Coronavirus updates: Johnson & Johnson pauses vaccine trial

The company is currently in Phase 3 of its trial.

Last Updated: October 13, 2020, 6:07 AM EDT

A pandemic of the novel coronavirus has now killed more than 1 million people worldwide.

Over 37.6 million people across the globe have been diagnosed with COVID-19, the disease caused by the new respiratory virus, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. The criteria for diagnosis -- through clinical means or a lab test -- has varied from country-to-country. Still, the actual numbers are believed to be much higher due to testing shortages, many unreported cases and suspicions that some national governments are hiding or downplaying the scope of their outbreaks.

Since the first cases were detected in China in December, the virus has rapidly spread to every continent except Antarctica.

The United States is the worst-affected country, with more than 7.7 million diagnosed cases and at least 214,771 deaths.

California has the most cases of any U.S. state, with more than 855,000 people diagnosed, according to Johns Hopkins data. California is followed by Texas and Florida, with over 818,000 cases and over 736,000 cases, respectively.

More than 190 vaccine candidates for COVID-19 are being tracked by the World Health Organization, at least 10 of which are in crucial phase three studies. Of those 10 potential vaccines in late-stage trials, there are currently five that will be available in the United States if approved.

Oct 12, 2020, 4:46 AM EDT

Mexico confirms 1st case of someone with both COVID-19 and influenza

Mexico has confirmed its first case of an individual who has tested positive for both COVID-19 and influenza at the same time.

Dr. Jose Luis Alomia Zegarra, director general of epidemiology at the Mexican Ministry of Health, told a press conference Sunday night that the case was detected in a 54-year-old woman with a number of preexisting conditions who remains hospitalized in stable condition after developing COVID-19 symptoms. She's a cancer survivor and suffers from autoimmune disease, chronic pulmonary issues as well as obesity, according to Zegarra.

Zegarra said the woman first displayed symptoms of COVID-19 at the end of September and was hospitalized. She tested positive for COVID-19 on Oct. 2 as she awaited the results of a panel of over a dozen viral exams. The patient started to receive therapy for COVID-19 and was later discharged from the hospital between Oct. 5 and Oct. 6 after her condition improved.

A pregnant woman with symptoms of COVID-19 receives medical attention at a health center in Tlapa de Comonfort, Guerrero state, Mexico, on Sept. 7, 2020.
Pedro Pardo/AFP via Getty Images

On Oct. 8, while at home, the woman started to have a fever and respiratory issues again. She was admitted to the hospital a second time, according to Zegarra.

On Saturday, the patient's full virus panel test returned with positive results for both COVID-19 and influenza, Zegarra said.

Since the start of the pandemic, Mexico's health ministry has confirmed more than 817,000 cases of COVID-19 with at least 83,781 deaths. The country has the four-highest death toll from COVID-19 in the world, according to tallies kept by Johns Hopkins University.

ABC News' Joshua Hoyos contributed to this report.

Related Topics